156 related articles for article (PubMed ID: 36990433)
1. The Disease Burden and Societal Costs of Hereditary Angioedema.
Fijen LM; Klein PCG; Cohn DM; Kanters TA
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2468-2475.e2. PubMed ID: 36990433
[TBL] [Abstract][Full Text] [Related]
2. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
Lumry WR; Zuraw B; Cicardi M; Craig T; Anderson J; Banerji A; Bernstein JA; Caballero T; Farkas H; Gower RG; Keith PK; Levy DS; Li HH; Magerl M; Manning M; Riedl MA; Lawo JP; Prusty S; Machnig T; Longhurst H;
Orphanet J Rare Dis; 2021 Feb; 16(1):86. PubMed ID: 33588897
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey.
Mendivil J; Murphy R; de la Cruz M; Janssen E; Boysen HB; Jain G; Aygören-Pürsün E; Hirji I; Devercelli G
Orphanet J Rare Dis; 2021 Feb; 16(1):94. PubMed ID: 33602292
[TBL] [Abstract][Full Text] [Related]
4. Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema.
Vanya M; Watt M; Shahraz S; Kosmas CE; Rhoten S; Costa-Cabral S; Mendivil J; Devercelli G; Weller K
J Patient Rep Outcomes; 2023 Apr; 7(1):33. PubMed ID: 37012445
[TBL] [Abstract][Full Text] [Related]
5. Long-term lanadelumab treatment improves health-related quality of life in patients with hereditary angioedema.
Lumry WR; Maurer M; Weller K; Riedl MA; Watt M; Yu M; Devercelli G; Meunier J; Banerji A;
Ann Allergy Asthma Immunol; 2023 Jul; 131(1):101-108.e3. PubMed ID: 37028510
[TBL] [Abstract][Full Text] [Related]
6. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
Lumry WR; Craig T; Zuraw B; Longhurst H; Baker J; Li HH; Bernstein JA; Anderson J; Riedl MA; Manning ME; Keith PK; Levy DS; Caballero T; Banerji A; Gower RG; Farkas H; Lawo JP; Pragst I; Machnig T; Watson DJ
J Allergy Clin Immunol Pract; 2018; 6(5):1733-1741.e3. PubMed ID: 29391286
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Treatment in Hereditary Angioedema Is Associated with Reduced Anxiety in Patients in Leipzig, Germany.
Zarnowski J; Rabe M; Kage P; Simon JC; Treudler R
Int Arch Allergy Immunol; 2021; 182(9):819-826. PubMed ID: 33887730
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in relation to disease activity in adults with hereditary angioedema in Sweden.
Nordenfelt P; Nilsson M; Lindfors A; Wahlgren CF; Björkander J
Allergy Asthma Proc; 2017 Nov; 38(6):447-455. PubMed ID: 28855002
[TBL] [Abstract][Full Text] [Related]
9. Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema.
Castaldo AJ; Jervelund C; Corcoran D; Boysen HB; Christiansen SC; Zuraw BL
Allergy Asthma Proc; 2021 Mar; 42(2):108-117. PubMed ID: 33581742
[No Abstract] [Full Text] [Related]
10. Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States.
Banerji A; Davis KH; Brown TM; Hollis K; Hunter SM; Long J; Jain G; Devercelli G
Ann Allergy Asthma Immunol; 2020 Jun; 124(6):600-607. PubMed ID: 32169514
[TBL] [Abstract][Full Text] [Related]
11. The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology.
Bygum A; Aygören-Pürsün E; Caballero T; Beusterien K; Gholizadeh S; Musingarimi P; Wait S; Boysen H
BMC Dermatol; 2012 Apr; 12():4. PubMed ID: 22536794
[TBL] [Abstract][Full Text] [Related]
12. Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study.
Lumry WR; Weller K; Magerl M; Banerji A; Longhurst HJ; Riedl MA; Lewis HB; Lu P; Devercelli G; Jain G; Maurer M;
Allergy; 2021 Apr; 76(4):1188-1198. PubMed ID: 33258114
[TBL] [Abstract][Full Text] [Related]
13. Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study.
Zanichelli A; Azin GM; Cristina F; Vacchini R; Caballero T
Orphanet J Rare Dis; 2018 Apr; 13(1):51. PubMed ID: 29631595
[TBL] [Abstract][Full Text] [Related]
14. Effect of COVID-19 on hereditary angioedema activity and quality of life.
Can Bostan O; Tuncay G; Damadoglu E; Karakaya G; Kalyoncu AF
Allergy Asthma Proc; 2021 Sep; 42(5):403-408. PubMed ID: 34474710
[No Abstract] [Full Text] [Related]
15. Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden.
Nordenfelt P; Dawson S; Wahlgren CF; Lindfors A; Mallbris L; Björkander J
Allergy Asthma Proc; 2014; 35(2):185-90. PubMed ID: 24411585
[TBL] [Abstract][Full Text] [Related]
16. Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives.
Otani IM; Christiansen SC; Busse P; Camargo CA; Zuraw BL; Riedl MA; Banerji A
J Allergy Clin Immunol Pract; 2017; 5(1):128-134.e4. PubMed ID: 27665386
[TBL] [Abstract][Full Text] [Related]
17. How Angioedema Quality of Life Questionnaire Can Help Physicians in Treating C1-Inhibitor Deficiency Patients?
Balla Z; Ignácz B; Varga L; Kőhalmi KV; Farkas H
Clin Rev Allergy Immunol; 2021 Aug; 61(1):50-59. PubMed ID: 33660212
[TBL] [Abstract][Full Text] [Related]
18. Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema.
Aygören-Pürsün E; Bygum A; Beusterien K; Hautamaki E; Sisic Z; Boysen HB; Caballero T
Patient Prefer Adherence; 2016; 10():1699-707. PubMed ID: 27660419
[TBL] [Abstract][Full Text] [Related]
19. Hereditary angioedema from the patient's perspective: A follow-up patient survey.
Banerji A; Li Y; Busse P; Riedl MA; Holtzman NS; Li HH; Davis-Lorton M; Bernstein JA; Frank M; Castaldo AJ; Long J; Zuraw B; Lumry W; Christiansen S
Allergy Asthma Proc; 2018 May; 39(3):212-223. PubMed ID: 29669666
[TBL] [Abstract][Full Text] [Related]
20. The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression.
Lumry WR; Castaldo AJ; Vernon MK; Blaustein MB; Wilson DA; Horn PT
Allergy Asthma Proc; 2010; 31(5):407-14. PubMed ID: 20929608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
